MLYCD

Malonyl-CoA decarboxylase, mitochondrial · O95822 · MLYCD on Sugi Atlas →

31,105 patent compounds predicted against MLYCD, 16,208 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL647139 SCHEMBL647139 1.00 20/20
SCHEMBL647659 SCHEMBL647659 1.00 20/20
SCHEMBL647994 SCHEMBL647994 1.00 20/20
SCHEMBL649339 SCHEMBL649339 1.00 20/20
SCHEMBL649300 SCHEMBL649300 0.75 20/20
SCHEMBL647138 SCHEMBL647138 0.70 20/20
SCHEMBL648037 SCHEMBL648037 0.69 20/20
SCHEMBL649533 SCHEMBL649533 0.67 20/20
SCHEMBL648813 SCHEMBL648813 0.62 20/20
SCHEMBL650108 SCHEMBL650108 0.58 20/20
SCHEMBL649056 SCHEMBL649056 0.55 20/20
SCHEMBL647661 SCHEMBL647661 0.53 20/20
SCHEMBL650860 SCHEMBL650860 0.52 20/20
SCHEMBL647634 SCHEMBL647634 0.52 19/20
SCHEMBL250966 SCHEMBL250966 0.58 18/20
SCHEMBL650015 SCHEMBL650015 0.54 17/20
SCHEMBL591541 SCHEMBL591541 0.47 16/20
Trifluoroacetic Acid Trifluoroacetic Acid (SCHEMBL22713) 0.39 15/20
SCHEMBL649587 SCHEMBL649587 0.50 14/20
SCHEMBL650043 SCHEMBL650043 0.56 13/20

Clinical trials — most relevant to MLYCD by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency: PHASE3ACTIVE_NOT_RECRUITING
Phase III Randomized Study of Sodium Dichloroacetate in Children With Congenital Lactic Acidosis PHASE3COMPLETED
Acetylcarnitine and Insulin Sensitivity PHASE2COMPLETED
A Study of Bezafibrate in Mitochondrial Myopathy PHASE2COMPLETED
Efficacy and Safety of the Treatment of Pyruvate Dehydrogenase Deficiency Patients With Glycerol Phenylbutyrate (RAVICTI) PHASE2RECRUITING
UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells PHASE1RECRUITING
Fatty Acid Oxidation Defects and Insulin Sensitivity nanCOMPLETED
Evaluation of Hydroxymethylbutyrate Supplementation in Lung Transplant Candidates Receiving Pulmonary Rehabilitation nanCOMPLETED
The Prevalence of Metabolic Liver Disorders in Children nanUNKNOWN
McArdle Disease Treatment by Ketogenic Diet nanCOMPLETED
Abnormalities in the Effects of Insulin and Exercise on Glucose- and Lipid Metabolism in Obesity and Type 2 Diabetes nanCOMPLETED
Photobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders for Alzheimer's Disease Prevention nanUNKNOWN
Lifestyle Intervention in Preparation for Pregnancy (LIPP) nanCOMPLETED
GDF-15 as a Biomarker for Mitochondrial Disease nanCOMPLETED
Metabolic Effects of Medium-Chain Fatty Acids in Patients With Medium-Chain Acyl-CoA Dehydrogenase Deficiency and Healthy Individuals nanRECRUITING
Natural History Study of FDXR Mutation-related Mitochondriopathy nanCOMPLETED
Tissue Sample Study for Mitochondrial Disorders nanENROLLING_BY_INVITATION
Natural History and Advanced Genetic Study of Pyruvate Dehydrogenase Complex Deficiencies nanRECRUITING
Nicotinamide Riboside and Mitochondrial Biogenesis nanCOMPLETED
MITOMICS : a Multi-OMICS Approach for the Diagnosis of Mitochondrial Diseases nanRECRUITING
Adjuvant Nitrate to Boost Exercise-induced Health Benefits in Older Adults nanNOT_YET_RECRUITING
Mitochondria and Metabolic Syndrome in a Southern California Chinese Cohort nanCOMPLETED
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
The RolE oF Androgen Excess in MUscle Energy MetaboLism in Women With PolyCystic Ovary Syndrome (REFUEL PCOS) Study 2 nanUNKNOWN
Nephroprotective Effects of Carnitine and (PDE5) Inhibitor Agent Against Contrast Media-induced Nephropathy (CMN) nanUNKNOWN
The Effect of Lowered Physical Activity on Insulin Sensitivity and Lipid and Glucose Metabolism nanCOMPLETED
Cardiac Manifestation and Inherited Metabolic Diseases nanCOMPLETED
Mitochondrial Dysfunction in Autism Spectrum Disorder nanACTIVE_NOT_RECRUITING
Natural History in Primary Mitochondrial Myopathies nanRECRUITING
Lactate Profile and Fat Oxidation During Exercise nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a MLYCD binder may also engage these)

ProteinNameSimilarity
Q99J39 1.000 Q99J39 →
Q920F5 1.000 Q920F5 →
P12617 0.999 P12617 →
Q9BVI4 0.988 Q9BVI4 →
C5WNV2 0.987 C5WNV2 →
P06623 0.986 P06623 →
A7MBC2 0.986 A7MBC2 →
KAT8 Histone acetyltransferase KAT8 0.986 landscape →
KDM5B Lysine-specific demethylase 5B 0.986 landscape →
KDM5D Lysine-specific demethylase 5D 0.986 landscape →
Q66HY8 0.985 Q66HY8 →
D3ZEY4 0.985 D3ZEY4 →
Q9STV0 0.985 Q9STV0 →
TBCD Tubulin-specific chaperone D 0.985 landscape →
A0A1D5AG16 0.985 A0A1D5AG16 →
Q5BJS0 0.985 Q5BJS0 →
Q8BHY2 0.985 Q8BHY2 →
Q5F259 0.984 Q5F259 →
Q5XUN4 0.984 Q5XUN4 →
F6S9E6 0.984 F6S9E6 →
B9IJ21 0.984 B9IJ21 →
Q9VDQ7 0.984 Q9VDQ7 →
Q90830 0.984 Q90830 →
Q8LI34 0.984 Q8LI34 →
Q61586 0.984 Q61586 →
Q6P996 0.984 Q6P996 →
Q1PS67 0.984 Q1PS67 →
A1A5V9 0.984 A1A5V9 →
P41230 0.984 P41230 →
Q6UB35 0.984 Q6UB35 →